Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Cash from Investing Activities (2016 - 2025)

iBio (IBIO) has disclosed Cash from Investing Activities for 16 consecutive years, with -$3.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 149050.0% to -$3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$24.4 million, a 1659.99% decrease, with the full-year FY2025 number at $742000.0, down 18.1% from a year prior.
  • Cash from Investing Activities was -$3.0 million for Q4 2025 at iBio, up from -$21.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $8.2 million in Q1 2023 to a low of -$21.5 million in Q3 2025.
  • A 5-year average of -$1.5 million and a median of -$6000.0 in 2023 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 1494.0% in 2023, then crashed 149050.0% in 2025.
  • iBio's Cash from Investing Activities stood at -$972000.0 in 2021, then fell by 29.12% to -$1.3 million in 2022, then surged by 103.98% to $50000.0 in 2023, then tumbled by 104.0% to -$2000.0 in 2024, then plummeted by 149050.0% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Cash from Investing Activities are -$3.0 million (Q4 2025), -$21.5 million (Q3 2025), and $45000.0 (Q2 2025).